OSTP

Dear Research Advocate, A New Budget Proposal : President Biden’s full FY22 budget request builds upon and modifies parts of the initial budget blueprint he released in April. Research!America applauded the President in our statement . NIH, CDC, AHRQ, FDA, and NSF would all receive significant increases to their base budgets under the President’s proposal. In a particularly welcome development, the President now recommends a base budget increase of $2.5 billion for NIH (exclusive of ARPA-H). See our updated budget chart here . Use this editable Tweet to thank the President for proposing a number of crucially important increases. Look for opportunities in upcoming letters to help ensure...
Dear Research Advocate, President Biden will release his FY22 budget tomorrow. We anticipate that it will be a great day for science, increasing public attention to the importance of science in meeting national goals. As you may remember, the President requested important increases for NIH, CDC, and NSF in his previously-released “skinny” budget and we expect those will remain in the full budget. FDA and AHRQ were not included in the earlier budget; we have been advocating for these important agencies to also receive solid increases. Research!America will be issuing a statement following the release of the full budget. Watch for that and know that we will keep you informed. Last week, we...
Dear Research Advocate, Did you miss our awards program last Thursday? These segments — a conversation between Dr. Anthony Fauci and Oprah Winfrey and a duet by Dr. Francis Collins and Renée Fleming — are emblematic of inspirational and affecting moments throughout this fast-moving event, which you can view in its entirety here . Bipartisan Support for Science on the Hill: In a strong signal of bipartisan support for bolstering U.S. science and technology, the Senate voted this week to invoke cloture (allow a full Senate vote on) the Endless Frontier Act, now rolled into a larger bill called the U.S. Innovation and Competition Act of 2021. Amendments to the EFA (the bill passed in committee...
Dear Research Advocate, On his 99th day in office, President Biden delivered a policy-focused address to a joint session of Congress. It featured a science strong message, noting how our nation is falling behind in our R&D investment, very much echoing the recommendations of the Science and Technology Action Plan that we’ve mentioned regularly in this letter. I was struck that the President equated the importance of breakthroughs for health security with breakthroughs in defense security – putting these investments, at least rhetorically, on a level playing field, of equally high value for the American public. View Research!America’s statement on the President’s remarks here . On the...
Dear Research Advocate, Earth Day: Today, people around the world are taking action to better the environment and our planet. As the public clearly recognizes , threats to the environment are threats to our health. Check out this evidence-based resource from The Medical Society Consortium on Climate and Health detailing the links between climate change and health. On the Hill: President Biden will give his first address to a joint session of Congress next Wednesday. If the Administration’s initial budget proposal is any indication, he will highlight the importance of robust investment in science & technology. In that context... Take Action Now: The President’s infrastructure package...
Dear Research Advocate, The Senate HELP Committee and House Energy and Commerce Committee held hearings this week to review the Biden Administration’s pandemic response and ongoing COVID-19 vaccine distribution with CDC Director Dr. Rochelle Walensky, NIH NIAID Director Dr. Anthony Fauci, HHS Chief Scientific Officer for the COVID Response Dr. David Kessler, and FDA CBER Director Dr. Peter Marks. In their testimonies, the Administration officials underscored how utilizing past scientific discoveries in combination with new partnerships led to the development of COVID-19 vaccines and therapeutics at a record pace. They also spoke to concerns regarding equitable vaccine distribution, and how...
Dear Research Advocate, Getting a fast start on assuring that our nation reclaims our – let’s face it – war-torn identity as a science-strong nation, the Biden Administration is moving full speed ahead. Consider PCAST (the President’s Council of Advisors on Science and Technology ). President Biden issued an Executive Order (EO) chartering his advisory council earlier than any of the last four administrations. (You can track all of the President’s EOs here .) The President elevating the director of the Office of Science and Technology Policy (OSTP) to a cabinet-level position is another straight-out-of-the-gate action. A cabinet-level science advisor is the first of three recommendations...
Dear Research Advocate, You may have paused yesterday in solidarity with the young scientists who galvanized the #ShutDownSTEM movement to listen and reflect on your personal and your organization’s role in ending racism; I did. The very first research project I was involved in worked hard to recruit its study volunteers from a diverse community; we were only modestly successful. That was more than 40 years ago; ensuring diversity in clinical trials is still a major obstacle. Overcoming health disparities is a related challenge, one that calls for — no, demands — far greater attention. Witness COVID-19. We may not know all the factors that are causing dramatically disproportionate harm to...
Dear Research Advocate: In welcome news, last night the (departing) 115th Senate voted to confirm Dr. Kelvin Droegemeier as Director of the White House Office of Science and Technology Policy (OSTP). Research!America sent a thank you note acknowledging the roles Senate Commerce Committee leaders John Thune (R-SD) and Bill Nelson (D-FL) played in advancing the nomination. This confirmation is a great beginning for the new year – and the most recent evidence that advocacy works! Tomorrow marks Research!America’s 30th anniversary. There is no question that over three decades, the medical and health research advocacy community has become more organized and more effective. While our community...
Dear Research Advocate: Votes and other Congressional activities were suspended this week to mourn the passing of our nation’s 41st President, George H.W. Bush. To prevent a government shutdown and provide more time to resolve disagreement around border wall funding, Congress agreed to another continuing resolution (CR) – now awaiting the President’s signature – to extend flat-funding for all remaining federal departments and agencies, including FDA and NSF, until December 21. This end-of-year CR scenario is all too familiar to advocates, and we must all stay the course to secure passage this year. Yesterday, Research!America and the Alliance for Aging Research sent a joint letter to...

Pages